A randomized control trail on the effectiveness of (Tricyclic antidepressant) Amitriptyline 10 mg bedtime in patients suffering from Meniere's disease
SK Rajamani, P Sahu - International Journal of Otorhinolaryngology and Head …, 2018
Background: Meniere's disease is one of the most common causes of chronic recurrent
vertigo in general population. Meniere's disease is closely associated with migraine and
migrainous vertigo/vestibular migraine. Amitriptyline has been classically used in
vertigo in general population. Meniere's disease is closely associated with migraine and
migrainous vertigo/vestibular migraine. Amitriptyline has been classically used in
USE OF AMISULPRIDE AS AN ANTI-EMETIC
JC Gilbert, RW Gristwood, N Cooper, G Fox - US Patent App. 15/790,481, 2018
… Conditions which are associated with vertigo, for example Meniere's disease, can also cause
the symptoms. Headache, caused by for example migraine, increased intracranial pressure
or cerebral vascular haemorrhage can also result in the symptoms …
the symptoms. Headache, caused by for example migraine, increased intracranial pressure
or cerebral vascular haemorrhage can also result in the symptoms …
Methods and compositions for preventing and treating auditory dysfunctions
US Patent 9,889,107, 2018
… 9, 2002, pp. 325-337 (Exhibit 12). S. Dharmananda "Treatment of tinnitus, vertigo, and
Meniere's disease with Chinese herbs", Institute of Traditional Medicine, Portland, Oregon,
http://ift.tt/2CLwC83 (Exhibit 13). M. Bors et al …
Meniere's disease with Chinese herbs", Institute of Traditional Medicine, Portland, Oregon,
http://ift.tt/2CLwC83 (Exhibit 13). M. Bors et al …
[PDF] Regulation of Inner Ear Secretion and Transport Mechanism
EA Cetinkaya, Y Chong - J Otolaryngol Forecast. 2018; 1 (1)
… glucocorticoids. Different glucocorticoid reseptors is present in differentsections of
the inner ear and thesesectionscan be a direct therapeutic target of glucocorticoids
in the inner ear diseases such as Meniere's disease [8-10] …
the inner ear and thesesectionscan be a direct therapeutic target of glucocorticoids
in the inner ear diseases such as Meniere's disease [8-10] …
GENETICALLY MODIFIED MESENCHYMAL STEM CELL EXPRESSING KLOTHO
C Günther, M Stangl, F Hermann - US Patent App. 15/553,954, 2018
A genetically modified mesenchymal stem cell (MSC) includes an exogenous
nucleic acid that includes a Klotho encoding region operably linked to a promoter
or promoter/enhancer combination. The MSCs ca.
nucleic acid that includes a Klotho encoding region operably linked to a promoter
or promoter/enhancer combination. The MSCs ca.
ENGINEERED POLYPEPTIDES AND USES THEREOF
K Viswanathan, B Ramakrishnan, B Booth, K Narayan… - US Patent App. 15/667,309, 2018
Polypeptides, such as antibody molecules and fusion proteins, comprising an Fc region, are
disclosed. The polypeptides can be used to treat, prevent, and/or diagnose disorders.
disclosed. The polypeptides can be used to treat, prevent, and/or diagnose disorders.
Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου